Mayo Clinic

Hospital


Location: Rochester, MN, United States (USA) (US) US

ISNI: 000000040459167X

ROR: https://ror.org/02qp3tb03

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients (2018) Bidadi B, Liu D, Kalari KR, Rübner M, Hein A, Beckmann M, Rack B, et al. Journal article Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium (2018) Rudolph A, Song M, Brook MN, Milne RL, Mavaddat N, Michailidou K, Bolla MK, et al. Journal article MyD88 and TLR4 Expression in Epithelial Ovarian Cancer (2018) Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Toloczko A, et al. Journal article Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab (2018) Ingle JN, Kalari KR, Wickerham DL, Von Minckwitz G, Fasching P, Furukawa Y, Mushiroda T, et al. Journal article Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018) Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, et al. Journal article A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk (2018) Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, et al. Journal article Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (2018) Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, et al. Journal article BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study (2018) Fasching P, Loibl S, Hu C, Hart SN, Shimelis H, Moore R, Schem C, et al. Journal article Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing (2018) Shimelis H, Laduca H, Hu C, Hart SN, Na J, Thomas A, Akinhanmi M, et al. Journal article The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity (2018) Colombo M, Lopez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, et al. Journal article